Search Count: 7
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2016-04-06 Classification: ligase/ligase inhibitor Ligands: 62R, SO4 |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2016-04-06 Classification: ligase/ligase inhibitor Ligands: 62T, SO4 |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2016-04-06 Classification: ligase/ligase inhibitor Ligands: 62Q |
![]() |
Organism: Fusobacterium nucleatum
Method: X-RAY DIFFRACTION Resolution:2.93 Å Release Date: 2015-10-07 Classification: RNA/INHIBITOR Ligands: K, MG, 51B |
![]() |
The Sar Development Of Dihydroimidazoisoquinoline Derivatives As Phosphodiesterase 10A Inhibitors For The Treatment Of Schizophrenia
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.11 Å Release Date: 2012-03-14 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: MG, ZN, 0JP |
![]() |
The Discovery Of Potent, Selectivity, And Orally Bioavailable Pyrozoloquinolines As Pde10 Inhibitors For The Treatment Of Schizophrenia
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.11 Å Release Date: 2012-01-25 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 0CV, MG, ZN, PO4 |
![]() |
Discovery Of Orally Active Pyrazoloquinoline As A Potent Pde10 Inhibitor For The Management Of Schizophrenia
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.28 Å Release Date: 2011-12-21 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: C1L, MG, ZN |